START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Valo Therapeutics Oy
Valo Therapeutics Oy
NextPoint Therapeutics, Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Innovent Biologics (Suzhou) Co. Ltd.
Celgene
Masonic Cancer Center, University of Minnesota
Valerio Therapeutics
Valerio Therapeutics
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center